Advertisement
UK markets close in 28 minutes

  • FTSE 100

    8,140.13
    +61.27 (+0.76%)
     

  • FTSE 250

    19,816.81
    +214.83 (+1.10%)
     

  • AIM

    755.10
    +1.98 (+0.26%)
     

  • GBP/EUR

    1.1665
    +0.0008 (+0.07%)
     

  • GBP/USD

    1.2462
    -0.0049 (-0.39%)
     

  • Bitcoin GBP

    51,228.70
    +385.32 (+0.76%)
     

  • CMC Crypto 200

    1,331.57
    -64.96 (-4.65%)
     

  • S&P 500

    5,108.01
    +59.59 (+1.18%)
     

  • DOW

    38,225.78
    +139.98 (+0.37%)
     

  • CRUDE OIL

    83.43
    -0.14 (-0.17%)
     

  • GOLD FUTURES

    2,343.10
    +0.60 (+0.03%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,173.70
    +256.42 (+1.43%)
     

  • CAC 40

    8,103.57
    +86.92 (+1.08%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

BioNTech, Fosun launch another COVID-19 vaccine trial

Reuters

BERLIN (Reuters) - Germany's BioNTech <BNTX.O> and China's Shanghai Fosun Pharmaceutical <600196.SS> on Wednesday announced the start of another COVID-19 vaccine trial in China with a total of 144 participants.

"The study is designed to support the regulatory approval process for the Chinese market and intends to confirm that the safety and immunogenicity profile observed in participants from the German and U.S. trials is comparable to that of Chinese participants," BioNTech said in a statement.

(Reporting by Thomas Seythal; Editing by Michelle Martin)